Zimmer M/L Taper Hip Prosthesis or M/L Taper Hip Prosthesis with Kinectiv Technology and Versys Femoral Head

The Zimmer M/L Taper docket alleges that a modular hip-stem design — pairing an M/L Taper or M/L Taper with Kinectiv Technology stem with a Versys femoral head — is prone to corrosion and fretting at the modular junction, releasing metal debris that can cause tissue damage, pain, and revision surgery. With a single action still pending years after centralization, this docket is, for practical purposes, in its final tail: the overwhelming majority of the original claim population has already moved through resolution.

That changes what funding looks like here. This is not a docket where inventory-level financing or portfolio structuring is realistic — there is essentially one remaining claim to evaluate, on its own facts. For that claimant, the relevant funding questions are the same ones that apply to any late-stage individual products-liability claim: the strength of the revision-surgery record, imaging and metal-ion testing confirming corrosion-related tissue damage, and how the claim compares to the outcomes already achieved by the many similar claims that resolved earlier in the docket's life. Because so much of the surrounding claim population has already resolved, there is unusually good comparative information available for pricing this kind of tail claim, even without a public settlement program to point to. That comparative depth is a meaningful advantage for pricing what is, in effect, a single-claim underwriting exercise.

Medical-lien exposure should be confirmed directly — hip revision surgery is a significant procedure, and Medicare or private-insurer liens tied to that surgery can represent a meaningful share of gross recovery. Criterica Capital's mass tort finance product can size an advance against this kind of individual, late-stage claim using the surrounding docket's resolved history as a comparative anchor, rather than pricing it in isolation.

A structural read on how this docket reached its current, largely resolved posture is available from Criterica Intelligence.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.